Literature DB >> 29027677

Comparison of plasma pharmacokinetics of Tanreqing solution between intratracheal aerosolization and intravenous injection in rats.

Cui Li1,2, Siyu Liu3, Gan Luo2, Guohua Wang2, Baoxian Zhang2, Qixia Nie2.   

Abstract

A rapid ultra high performance liquid chromatography tandem mass spectrometry method was developed for the simultaneous analysis of baicalin, oroxylin A-7-O-β-d-glucoronide and chlorogenic acid in rats plasma, and applied to comparison of pharmacokinetics of Tanreqing solution between intratracheal aerosolization and intravenous injection. Results of the analytical method validation assay showed high sensitivity, accuracy and suitable recovery. Results of pharmacokinetics showed similar decline phases for baicalin, oroxylin A-7-O-β-d-glucoronide and chlorogenic acid in two different delivery routes. The half-lives of intratracheal aerosolization and intravenous injection were 0.90 and 1.22 h for baicalin, 0.47 and 0.17 h for oroxylin A-7-O-β-d-glucoronide and 0.22 and 0.13 h for chlorogenic acid, and this implies that compounds were retained in the lung for a relatively short time. This study was the first to provide important pharmacokinetics information for traditional Chinese medicine delivery to the lung.
Copyright © 2017 John Wiley & Sons, Ltd.

Entities:  

Keywords:  Tanreqing solution; UHPLC-MS/MS; intratracheal aerosolization; intravenous injection; plasma pharmacokinetics

Mesh:

Substances:

Year:  2017        PMID: 29027677     DOI: 10.1002/bmc.4116

Source DB:  PubMed          Journal:  Biomed Chromatogr        ISSN: 0269-3879            Impact factor:   1.902


  3 in total

1.  In vitro antibacterial effects of Tanreqing injection combined with vancomycin or linezolid against methicillin-resistant Staphylococcus aureus.

Authors:  Weifeng Yang; Jueling Liu; Biljana Blažeković; Yanan Sun; Shuhua Ma; Chuanyun Ren; Sanda Vladimir-Knežević; Chaohua Li; Yajun Xing; Guijie Tian; Yi Wang
Journal:  BMC Complement Altern Med       Date:  2018-05-30       Impact factor: 3.659

2.  Feasibility Studies of Nebulized SARS-CoV-2 Neutralizing Antibody in Mice and Cynomolgus Monkeys.

Authors:  Jilei Jia; Zhaojuan Yin; Xiao Zhang; Huimin Li; Dan Meng; Qianqian Liu; Hongfang Wang; Meng Han; Shixiang Suo; Yan Liu; Ping Hu; Chunyun Sun; Jing Li; Liangzhi Xie
Journal:  Pharm Res       Date:  2022-07-26       Impact factor: 4.580

3.  Effects and safety of Tanreqing injection on viral pneumonia: A protocol for systematic review and meta-analysis.

Authors:  Yue Qiu; Xue Pan; Lin Su; Hui Lui; Ya-Dong Li
Journal:  Medicine (Baltimore)       Date:  2020-09-11       Impact factor: 1.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.